HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Lhasa Beer Festival blends tradition with modernity
- Beijing introduces temporary no-fly zones for upcoming commemorative events
- Dual metropolises in SW China issue heat alerts
- China launches summer campaign to tackle harmful online content targeting minors
- Xi's article on unswervingly advancing high-standard opening-up to be published
- Toad soup video sparks enforcement review, controversial fine revoked